Metal effects on the membrane interactions of amyloid-β peptides

European Biophysics Journal

Volumn 37, Issue 3, 2008, Pages 333-344

  Gehman, John D ^a   O'Brien, Caitlin C ^a   Shabanpoor, Fazel ^a,b   Wade, John D ^b   Separovic, Frances ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Alzheimer's disease; Amyloid A ; Cholesterol; Metal interactions; Peptide lipid interactions; Phospholipid membranes; Solid state NMR; Structure

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[25-35]; COPPER; METAL; ZINC;

BILAYER MEMBRANE; BRAIN CORTEX; CELL CULTURE; CELL MEMBRANE; CONFERENCE PAPER; LIPID BILAYER; NUCLEAR MAGNETIC RESONANCE; PHOSPHOLIPID MEMBRANE; PROTEIN INTERACTION; PROTEIN STRUCTURE; SOLID STATE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; COPPER; LIPID BILAYERS; LIPOSOMES; MEMBRANE PROTEINS; METALLOPROTEINS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDE FRAGMENTS; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY;

EID: 39749176991     PISSN: 01757571     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00249-007-0251-2     Document Type: Conference Paper

References (83)

1. Aime S, Bertini I, Luchinat C (1996) Considerations on high resolution solid state NMR in paramagnetic molecules. Coord Chem Rev 150:221-242
2. Ali FE, Barnham KJ, Barrow CJ, Separovic F (2004) Metal catalyzed oxidative damage and oligomerization of the amyloid-β peptide (Aβ) of Alzheimer's disease. Aust J Chem 57:511-518
3. Alzheimer A (1907) Über eigenartige Erkrankung der Hirinde. Allg Zschr Psychiat U Psychich-gerchtl Med 64:146-148
4. Andrew ER, Bradbury A, Eades RG (1958) Nuclear magnetic resonance spectra from a crystal rotated at high speed. Nature 182:1659
5. Andrew ER, Bradbury A, Eades RG (1959) Removal of dipolar broadening of nuclear magnetic resonance spectra of solids by specimen rotation. Nature 183:1802-1803
6. Arispe N, Doh M (2002) Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AbetaP (1-40) and (1-42) peptides. FASEB J 16:1526-1536
7. Atwood CS, Scarpa RC, Huang X, Moir RD, Jones WD, Fairlie DP, Tanzi RE, Bush AI (2000) Characterization of copper interactions with Alzheimer Aβ peptides: Identification of a attomolar affinity copper binding site on Aβ1-42. J Neurochem 75:1219-1233
8. Balla MS, Bowie JH, Separovic F (2004) Solid-state NMR study of antimicrobial peptides from Australian frogs in phospholipid membranes. Eur Biophys J 33:109-116
9. Brown MF, Seelig J (1978) Influence of cholesterol on the polar region of phosphatidylcholine and phosphatidylethanolamine bilayers. Biochemistry 17:381-384
10. Barnham KJ, Ciccotosto GD, Tickler AK, Ali FE, Smith DG, Williamson NA, Lam YH, Carrington D, Tew D, Kocak G, Volitakis I, Separovic F, Barrow CJ, Wade JD, Masters CL, Cherny RA, Curtain CC, Bush AI, Cappai R (2003) Neurotoxic, redox-competent Alzheimer's beta-amyloid is released from lipid membrane by methionine oxidation. J Biol Chem 178:42959-42965
11. Barnham KJ, Haeffner F, Ciccotosto GD, Curtain CC, Tew D, Mavros C, Beyreuther K, Carrington D, Masters CL, Cherny RA, Cappai R, Bush AI (2004) Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease β-amyloid. FASEB J 18:1427-1429
12. Biological Magnetic Resonance Data Bank (2007) The University of Wisconsin, Madison. http://www.bmrb.wisc.edu. Cited 18 Aug 2007
13. Bokvist M, Lindström F, Watts A, Gröbner G (2004) Two types of Alzheimer's β-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation. J Mol Biol 335:1039-1049
14. Burdick D, Soreghan B, Kwon M, Kosmoski J, Knauer M, Henschen A, Yates J, Cotman C, Glabe C (1992) Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J Biol Chem 267:546-554
15. Bush AI (2003) The metallobiology of Alzheimer's disease. Trends Neurosci 26:207-214
16. Cherny RA, Atwood CS, Xilinas ME, Gray DN, Jones WD, McLean CA, Barnham KJ, Volitakis I, Fraser FW, Kim Y, Huang X, Goldstein LE, Moir RD, Lim JT, Beyreuther K, Zheng H, Tanzi RE, Masters CL, Bush AI (2001) Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30:665-676
17. Chochina SV, Avdulov NA, Igbavboa U, Cleary JP, O'Hare EO, Wood WG (2001) Amyloid beta-peptide 1-40 increases neuronal membrane fluidity: role of cholesterol and brain region. J Lipid Res 42:1292-1297
18. Choo-Smith LP, Garzon-Rodriguez W, Glabe CG, Surewicz WK (1997) Acceleration of amyloid fibril formation by specific binding of A beta-(1-40) peptide to ganglioside-containing membrane vesicles. J Biol Chem 272:22987-22990
19. Christian H, Simon G, Victor AG, Patrick H, Mallot HA (2007) Soluble beta-amyloid[25-35] reversibly impairs hippocampal synaptic plasticity and spatial learning. Eur J Pharmacol 561:85-90
20. Coles M, Bicknell W, Watson AA, Fairlie DP, Craik DJ (1998) Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is? Biochemistry 37:11064-11077
21. Cornell BA, Hiller RG, Raison J, Separovic F, Smith R, Vary JC, Morris C (1983) Biological membranes are rich in low frequency motion. Biochim Biophys Acta 732:473-478
22. Cornell BA, Weir LE, Separovic F (1988) The effect of gramicidin A on phospholipid bilayers. Eur Biophys J 16:113-119
23. Curtain CC, Separovic F, Rivett D, Kirkpatrick A, Waring AJ, Gordon LM, Azad AA (1994) The amino-terminal region of the HIV-1 Nef protein is fusogenic. AIDS Res Hum Retroviruses 10:1231-1240
24. Demeester N, Baier G, Enzinger C, Goethals M, Vandekerckhove J, Rosseneu M, Labeur C (2000) Apoptosis induced in neuronal cells by C-terminal amyloid β-fragments is correlated with their aggregation properties in phospholipid membranes. Mol Membr Biol 17:219-228
25. de Planque MRR, Rijkers DTS, Fletcher J, Liskamp RMJ, Separovic F (2004) The αM1 segment of the nicotinic acetylcholine receptor exhibits conformational flexibility in a membrane environment. Biochim Biophys Acta 1665:40-47
26. Donnelly PS, Xiao Z, Wedd AG (2007) Copper and Alzheimer's disease. Curr Opin Chem Biol 11:128-133
27. Dufourc EJ, Mayer C, Stohrer J, Althoff G, Kothe G (1992) Dynamics of phosphate head groups in biomembranes. Comprehensive analysis using phosphorus-31 nuclear magnetic resonance lineshape and relaxation time measurements. Biophys J 61:42-57
28. Fassbender K, Masters C, Beyreuther K (2001) Alzheimer's disease: molecular concepts and therapeutic targets. Naturwissenschaften 88:261-267
29. Fung BM, Khitrin AK, Ermolaev K (2000) An improved broadband decoupling sequence for liquid crystals and solids. J Magn Reson 142:97-101
30. Gehman JD, Separovic F (2006) Solid-State NMR of Membrane-Active Proteins and Peptides. In: Webb GA (ed) Modern magnetic resonance. Springer, Heidelberg, pp 301-307
31. Gehman JD, Separovic F, Lu K, Mehta AK (2007) Boltzmann statistics rotational-echo double-resonance analysis. J Phys Chem B 111:7802-7811
32. Glenner GG, Wong CW (1984) Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885-890
33. Griffin RG, Powers L, Pershan PS (1978) Head-group conformation in phospholipids: a phosphorus-31 nuclear magnetic resonance study of oriented monodomain dipalmitoylphosphatidylcholine bilayers. Biochemistry 17:2718-2722
34. Harper JD, Lansbury PT Jr (1997) Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem 66:385-407
35. Hartley DM, Walsh DM, Ye CP, Diehl T, Vasquez S, Vassilev PM, Teplow DB, Selkoe DJ (1999) Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci 19:8876-8884
36. Hartzell CJ, Whitfield M, Oas TG, Drobny GP (1987) Determination of the 15N and 13C chemical shift tensors of L-[13C]alanyl-L-[15N]alanine from the dipole-coupled powder patterns. J Am Chem Soc 109:5966-5969
37. Herzfeld J, Griffin RG, Haberkorn RA (1978) Phosphorus-31 chemical-shift tensors in barium diethyl phosphate and urea-phosphoric acid: model compounds for phospholipid head-group studies. Biochemistry 17:2711-2718
38. Herzfeld J, Berger AE (1980) Sideband intensities in NMR spectra of samples spinning at the magic angle. J Chem Phys 73:6021-6030
39. Jick J, Zornberg GL, Jick SS, Seshadri S, Drachman DA (2000) Statins and the risk of dementia. Lancet 356:1627-1631
40. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Muller-Hill B (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325:733-736
41. Kanski J, Varadarajan S, Aksenova M, Butterfield DA (2001) Role of glycine-33 and methionine-35 in Alzheimer's amyloid β-peptide 1-42-associated oxidative stress and neurotoxicity. Biochim Biophys Acta 1586:190-198
42. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300:486-489
43. Kohler SJ, Klein MP (1976) 31P nuclear magnetic resonance chemical shielding tensors of phosphorylethanolamine, lecithin, and related compounds: applications to head-group motion in model membranes. Biochemistry 15:967-974
44. Kohler SJ, Klein MP (1977) Orientation and dynamics of phospholipid head groups in bilayers and membranes determined from 31P nuclear magnetic resonance chemical shielding tensors. Biochemistry 16:519-526
45. Kurland RJ, McGarvey BR (1970) Isotropic NMR shifts in transition metal complexes: the calculation of the Fermi contact and pseudocontact terms. J Magn Reson 2:286-301
46. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL (1998) Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95:6448-6453
47. Lau T-L, Barnham KJ, Curtain CC, Masters CL, Separovic F (2003) Magnetic resonance studies of the β-amyloid peptide. Aust J Chem 56:349-356
48. Lau T-L, Ambroggio EE, Tew DJ, Cappai R, Masters CL, Fidelio GD, Barnham KJ, Separovic F (2006) Amyloid-β peptide disruption of lipid membranes and the effect of metal ions. J Mol Biol 356:759-770
49. Lau T-L, Gehman JD, Wade JD, Masters CL, Barnham KJ, Separovic F (2007a) Cholesterol and Clioquinol modulation of Aβ(1-42) interaction with phospholipids bilayers and metals. Biochim Biophys Acta 1768:2400-2408
50. Lau T-L, Gehman JD, Wade JD, Perez K, Masters CL, Barnham KJ, Separovic F (2007b) Membrane interactions and the effect of metal ions of the amyloidogenic fragment Aβ(25-35) in comparison to Aβ(1-42). Biochim Biophys Acta 1768:2400-2408
51. Lesné S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH (2006) A specific amyloid-β protein assembly in the brain impairs memory. Nature 440:352-357
52. Lowe IJ (1959) Free induction decays of rotating solids. Phys Rev Lett 2:285-287
53. Maricq MM, Waugh JS (1979) NMR in rotating solids. J Chem Phys 70:3300-3316
54. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer disease and down syndrome. Proc Natl Acad Sci 82:4245-4249
55. McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K, Bush AI, Masters CL (1999) Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol 46:860-866
56. Mehring M (1983) Principles of high resolution NMR in solids. Springer, Heidelberg
57. Oas TG, Hartzell CJ, McMahon TJ, Drobny GP, Dahlquist FW (1987) The carbonyl 13C chemical shift tensors of five peptides determined from 15N dipole-coupled chemical shift powder patterns. J Am Chem Soc 109:5956-5962
58. Pake GE (1948) Nuclear resonance absorption in hydrated crystals: fine structure of the proton line. J Chem Phys 16:327-336
59. Petkova AT, Ishii Y, Balbach JJ, Antzutkin ON, Leapman RD, Delaglio F, Tycko R (2002) A structural model for Alzheimer's beta-amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci USA 99:16742-16747
60. Roher AE, Lowenson JD, Clarke S, Woods AS, Cotter RJ, Gowing E, Ball MJ (1993) β-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. Proc Natl Acad Sci USA 90:10836-10840
61. Saitô H (1983) Conformation-dependent 13C chemical shifts: a new means of conformational characterization as obtained by high-resolution solid-state NMR. Magn Reson Chem 24:835-852
62. Saitô H, Tuzi S, Yamaguchi S, Kimura S, Tanio M, Kamihira M, Nishimura K, Naito A (1998) Conformation and dynamics of membrane proteins and biologically active peptides as studied by high-resolution 13C NMR. J Mol Struct 441:137-148
63. Schmidt-Rohr K, Spiess HW (1994) Multidimensional solid-state NMR and polymers. Academic Press, San Diego
64. Seelig J, Gally H (1976) Investigation of phosphatidylethanolamine bilayers by deuterium and phosphorus-31 nuclear magnetic resonance. Biochemistry 15:5199-5204
65. Separovic F, Smith R, Yannoni CS, Cornell BA (1990) Molecular sequence effect on the 13C carbonyl chemical shift shielding tensor. J Am Chem Soc 112:8324-8328
66. 1ρ, in lipid bilayers. Chem Phys Lipids 107:159-167
67. Separovic F, Drechsler A, Lau T-L (2004) Magnetic moments: membrane protein structures by NMR. Chem Aust 71(1):4-7
68. Singer SJ, Nicolson GL (1972) The fluid mosaic model of the structure of cell membranes. Science 175:720-731
69. Sisodia SS (1992) β-Amyloid precursor protein cleavage by a membrane-bound protease. Proc Natl Acad Sci USA 89:6075-6079
70. Smith DP, Smith DG, Curtain CC, Boas JF, Pilbrow JR, Ciccotosto GD, Lau T-L, Tew DJ, Perez K, Wade JD, Bush AI, Drew SC, Separovic F, Masters CL, Cappai R, Barnham KJ (2006) Copper-mediated amyloid-β toxicity is associated with an intermolecular histidine bridge. J Biol Chem 281:15145-15154
71. Smith DG, Cappai R, Barnham KJ (2007) The redox chemistry of the Alzheimer's disease amyloid beta peptide. Biochim Biophys Acta 1768:1976-1990
72. Sparks DL, Hunsaker JC, Scheff SW, Kryscio RJ, Henson JL, Markesbery WR (1990) Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease. Neurobiol Aging 11:601-607
73. 2O. J Magn Reson 55:266-273
74. Stejskal EO, Schaefer J, Waugh JS (1977) Magic-angle spinning and polarization transfer in proton-enhanced NMR. J Magn Reson 28:105-112
75. Stockton GW, Smith IC (1976) A deuterium nuclear magnetic resonance study of the condensing effect of cholesterol on egg phosphatidylcholine bilayer membranes. I. Perdeuterated fatty acid probes. Chem Phys Lipids 17:251-263
76. Subasinghe S, Unabia S, Barrow CJ, Mok SS, Aguilar MI, Small DH (2003) Cholesterol is necessary both for the toxic effect of Abeta peptides on vascular smooth muscle cells and for Abeta binding to vascular smooth muscle cell membranes. J Neurochem 84:471-479
77. Suckling KE, Boyd GS (1976) Interactions of the cholesterol side-chain with egg lecithin. A spin label study. Biochim Biophys Acta 436:295-300
78. Tickler AK, Wade JD, Separovic F (2005) The role of A beta peptides in Alzheimer's disease. Protein Peptide Lett 12:513-519
79. Varadarajan S, Kanski J, Aksenova M, Lauderback C, Butterfield DA (2001) Different mechanisms of oxidative stress and neurotoxicity for Alzheimer's A beta(1-42) and A beta(25-35). J Am Chem Soc 123:5625-5631
80. Watwe RM, Bellare JR (1995) Manufacture of liposomes-a review. Curr Sci 68:715-724
81. Yeagle PL, Hutton WC, Huang CH, Martin RB (1975) Headgroup conformation and lipid- cholesterol association in phosphatidylcholine vesicles: a 31P{1H} nuclear Overhauser effect study. Proc. Natl Acad Sci USA 72:3477-3481
82. Yeagle PL, Hutton WC, Huang CH, Martin RB (1977) Phospholipid head-group conformations; intermolecular interactions and cholesterol effects. Biochemistry 16:4344-4349
83. 1-42 through p53 and Bax in cultured primary human neurons. J Cell Biol 156:519-529